In such experimental paradigms of myeloid leukemiagenesis, CD44 seems capable of purporting the activity of leukemia-initiating cells following their sequential transplantations into diverse hosts [4, 80, 82, 85, 93]. The gene discussed is CD44; the disease is leukemia.